Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Akers Biosciences, Inc.

TRADE

NASDAQ: AKERHealthcare / Medical Instruments & Supplies / USA
0.26+0.01+4.00%Vol 4 699 2711Y Perf -70.99%
Sep 25th, 2018 16:00
BID0.26 ASK0.26
Open0.24 Previous Close0.25
Pre-Market- After-Trading0.28
 - -%  0.02 7.69%
Target Price
- 
Analyst Rating
— 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)24 
Earnings Rating
Price Range Ratio 52wk %
8.24 
Earnings Date

Today's Price Range

0.240.28

 

52wk Range

0.121.82

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
4.00%
3 Months
-29.73%
6 Months
-71.74%
1 Year
-70.99%
3 Years
-91.80%
5 Years
-96.08%

Quotes

Name / TickerPriceChg.Chg.%
AKER0.260.01004.00
AAPL222.191.40000.63
GOOG1 184.6511.28000.96
MSFT114.45-0.2200-0.19
XOM86.50-0.1000-0.12
WFC54.23-0.0300-0.06
JNJ138.64-1.8300-1.30
FB164.91-0.5000-0.30
GE11.27-0.4700-4.00
JPM116.39-0.3300-0.28
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.70
Current Ratio 5.70
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -2 452.90
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin51.30
EBIT Margin-227.80
EBITDA Margin-219.80
Pre-tax Profit Margin-165.10
Profit Margin-83.41
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.18
PS Ratios 8.13
Price to Cash Flow 44.60
Price to Free Cash Flow -3.70
Cash Flow Per Share -0.07
Price to Tangible Book2.41
Book Value per Share0.11
Enterprise Value (in ths.)15 282
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-77.92
ROE last 12 Months -94.68
Return on Assets (5Y Avg) -47.59
ROA last 12 Months -78.40
Return on Capital (5Y Avg) -66.27
ROC last 12 Months -96.23
Return on invested Capital Q -19.05
Return on invested Capital Y-108.24
Assets Turnover0.30
Receivables Turnover4.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)2 893
Revenue per Share 0.03
Revenue Growth 3 Years 8.06
Revenue Growth 5 Years -2.46
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2016--0.19-
Q01 2016--0.28-
Q04 2015--0.69-
Q03 2015--0.36-
Q02 2015--0.41-
Q01 2015--0.26-
Q04 2014--0.19-
Q03 2014--0.23-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date13th Aug 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume4 699 271
Shares Outstanding (in ths.)94 110
Trades Count3 005
Dollar Volume1 212 553
Avg. Volume9 092 932
Avg. Weekly Volume2 243 747
Avg. Monthly Volume2 124 077
Avg. Quarterly Volume2 304 710

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

76%24%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x